STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
82 hedge funds and large institutions have $310M invested in Stemline Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
86% less call options, than puts
Call options by funds: $296K | Put options by funds: $2.15M
Holders
82
Holding in Top 10
1
Calls
$296K
Puts
$2.15M
Top Buyers
| 1 | +$20.4M | |
| 2 | +$8.95M | |
| 3 | +$8.06M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$8.02M |
| 5 |
NC
Nexthera Capital
New York
|
+$8.01M |
Top Sellers
| 1 | -$5.29M | |
| 2 | -$4.68M | |
| 3 | -$3.52M | |
| 4 |
CCS
Crosspoint Capital Strategies
Orinda,
California
|
-$1.03M |
| 5 |
JPMorgan Chase & Co
New York
|
-$721K |